These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16984582)

  • 1. Portal systemic collateral development: is it a trophic adaptation mechanism to hepatic deprivation?
    Aller MA; Arias J
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1643-5. PubMed ID: 16984582
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of norepinephrine and acetylcholine on portal-systemic collaterals of common bile duct-ligated cirrhotic rat.
    Chan CC; Chang CC; Huang HC; Wang SS; Lee FY; Chang FY; Lin HC; Tai CC; Lee SD
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1867-72. PubMed ID: 16336446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
    Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
    Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
    Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD
    Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gap junctions modulating hepatic vascular tone in cirrhosis.
    Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E
    Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal.
    Bosch J
    Clin Gastroenterol; 1985 Jan; 14(1):169-84. PubMed ID: 2859134
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats.
    Hsu SJ; Wang SS; Hsin IF; Huang HC; Lee FY; Lee JY; Lin HC; Chuang CL; Lee SD
    Scand J Gastroenterol; 2013 Jul; 48(7):831-8. PubMed ID: 23672611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium.
    Mosca P; Lee FY; Kaumann AJ; Groszmann RJ
    Am J Physiol; 1992 Oct; 263(4 Pt 1):G544-50. PubMed ID: 1415713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin.
    Chan CC; Lee FY; Wang SS; Chang FY; Lin HC; Chu CJ; Tai CC; Lai IN; Lee SD
    Hepatology; 1999 Sep; 30(3):630-5. PubMed ID: 10462367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of portal hypertension].
    Montaño-Loza A; Meza-Junco J
    Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic indomethacin treatment enhances the portal-systemic collateral vascular response to vasopressin in bile-duct ligated rats.
    Huang HC; Wang SS; Chang CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Lee SD
    J Chin Med Assoc; 2007 Dec; 70(12):521-6. PubMed ID: 18194892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
    Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
    Marra F; Pinzani M
    Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term portal hypertension increases the vasodilator response to acetylcholine in rat aorta: role of prostaglandin I2.
    Blanco-Rivero J; Aller MA; Arias J; Ferrer M; Balfagón G
    Clin Sci (Lond); 2009 Sep; 117(10):365-74. PubMed ID: 19331646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive rats.
    Huang HC; Wang SS; Chen YC; Lee FY; Chang FY; Lin HC; Hou MC; Chang CC; Lee SD
    Scand J Gastroenterol; 2006 Dec; 41(12):1440-5. PubMed ID: 17101575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
    Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
    J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
    Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.
    Fernandez M; Vizzutti F; Garcia-Pagan JC; Rodes J; Bosch J
    Gastroenterology; 2004 Mar; 126(3):886-94. PubMed ID: 14988842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.